Thoracic Cancer · 2014 · 12 citations · 22 references
Veterinary MedicineCell BiologyOncologyCellular PathologyMolecular OncologyNeoplasiaAnimal Cell CultureEpithelial TumorsMalignant NeoplasmsMalignant TumorsMediastinal TumorsThymic Epithelial TumorsCell Line ImmortalizationCell Line SelectionSuspension Cell CultureThymic PathologyThymic TumorsThymoma-associated Myasthenia GravisTissue Explant Culture
BACKGROUND: Thymoma is a cancer with rare incidence, but it is a major malignancy in adult anterior mediastinum, occurring in about 40% of patients with myasthenia gravis. Because of the lack of thymic epithelial tumor cell lines, thymoma has lagged far behind other tumors in cytological studies. It is, therefore, quite necessary to establish a new thymic epithelial tumor cell line from Chinese patients to study the pathogenic mechanism and therapeutic methods. METHODS: Twenty-three samples of tumor tissues were collected from thymoma and thymic carcinoma patients for primary culture by tissue explant, suspension cell culture method, and collagenase digestion. We detected the biological characteristics and origin of the cell line after the establishment of a novel thymoma cell line. RESULTS: A novel cell line, designed as Thy0517, was established from thymoma type AB with myasthenia gravis patients by tissue explant. As an immortalized cell line, it always has a stable growth cycle, and there is no change in characteristics and morphology after culturing for 18 months and passing 160 generations in vitro. The experimental data demonstrate that the cell line exhibits the growth characteristics of tumor cells, the doubling time of 37 hours, with tumorigenicity in vitro and chromosome abnormality. Immunocytochemistry indicated that the cell line positive expression of CK7, CK8/18, CK19, CK-pan, CD24, BCL-2, P63, Vimentin, epithelial membrane antigen and epidermal growth factor receptor, lymphocyte related antigen CD99, and TdT were negatively expressed. CONCLUSIONS: The newly established thymic epithelial tumor cell line from Chinese patients provides a model in the study of thymoma and molecularly targeted therapies.
22
Cancer stem cells from colorectal cancer-derived cell lines
Trevor M. Yeung, Shaan C. Gandhi, Jennifer L. Wilding et al. · Proceedings of the National Academy of Sciences · 2010 · 482 citations · Full text
Medicine, Cell Biology, Oncology +17
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
M-Q Gao, Y-P Choi, Suki Kang et al. · Oncogene · 2010 · 392 citations · Full text
Medicine, Cell Biology, Oncology +16
Identification of CD44+CD24+ gastric cancer stem cells
Chaojun Zhang, Chenwei Li, Fengtian He et al. · Journal of Cancer Research and Clinical Oncology · 2011 · 229 citations · Full text
Medicine, Cell Biology, Oncology +12
Recurrent Genetic Aberrations in Thymoma and Thymic Carcinoma
Andreas Zettl, Philipp Ströbel, Tiemo Katzenberger et al. · American Journal Of Pathology · 2000 · 169 citations